4//SEC Filing
AUERBACH ALAN H 4
Accession 0001437749-24-008575
CIK 0001401667other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 9:01 PM ET
Size
7.6 KB
Accession
0001437749-24-008575
Insider Transaction Report
Form 4
AUERBACH ALAN H
DirectorPresident and CEO10% Owner
Transactions
- Award
Common Stock
2024-03-15+6,577→ 7,104,320 total - Award
Stock Option (Right to Buy)
2024-03-15+9,047→ 9,047 totalExercise: $5.00Exp: 2034-03-14→ Common Stock (9,047 underlying)
Footnotes (3)
- [F1]Reflects supplemental annual equity awards due to an administrative error in the calculations used to determine the original number of shares underlying the annual equity awards.
- [F2]Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units ("RSUs") shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events.
- [F3]Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001358285
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 9:01 PM ET
- Size
- 7.6 KB